Breast Cancer
1. http://www.who.int/cancer/prevention/diagnosis-screening/breast-cancer/en/

Colorectal Cancer
1. Global patterns and trends in colorectal cancer incidence and mortality. Melina Arnold1, Mónica S Sierra1, Mathieu Laversanne1, Isabelle oerjomataram1, Ahmedin Jemal2, Freddie Bray1. Arnold M, et al. Gut 2017;66:683–691. doi:10.1136/gutjnl-2015-310912 683

Hematological Malignancies
1. Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability,and Disability-Adjusted Life-Years for 29 Cancer Groups,1990 to 2016. A Systematic Analysis for the Global Burden of Disease Study. Christina Fitzmaurice,MD, MPH, Division of Hematology, Department of Medicine, Institute for Health Metrics and Evaluation, University of Washington, 2301 5th Ave, Ste 600, Seattle,WA 98121

Liver Cancer
1. IARC database of 2018.
2. JAMA Oncol. 2017;3(12):1683-1691. doi:10.1001/jamaoncol.2017.3055Published online October 5, 2017. Corrected on December 14, 2017.

Liung Cancer
1. Dela Cruz CS, Tanoue LT, Matthay RA. Lung cancer: epidemiology, etiology, and prevention. Clin Chest Med. 2011;32(4):605-44. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3864624/#R1
2. Lung and Bronchus Cancer - Cancer Stat Facts. https://seer.cancer.gov/statfacts/html/lungb.html
3. National Cancer Institute. (2018). National Lung Screening Trial. [online] Available at: https://www.cancer.gov/types/lung/research/nlst [Accessed 5 Nov. 2018].
4. Acr.org. (2018). Nelson Lung Cancer Screening Study Confirms NLST Results. [online] Available at: https://www.acr.org/Media-Center/ACR-News-Releases/2018/Nelson-Lung-Cancer-Screening-Study-Confirms-NLST-Results [Accessed 5 Nov. 2018].
5. NELSON Study Shows CT Screening for Nodule Volume Management Reduces Lung Cancer Mortality by 26 Percent in Men [Internet]. IASLC; 2018 [cited 5 November 2018]. Available from: https://wclc2018.iaslc.org/media/2018%20WCLC%20Press%20Program%20Press%20Release%20De%20Koning%209.25%20FINAL%20.pdf
6. The FDA has cleared the following qualified GE Healthcare CT scanners to receive the new low-dose CT Lung Cancer Screening Option: RevolutionTM CT, Revolution GSI, Revolution HD, Revolution EVO, Revolution DiscoveryTM CT, Discovery CT750 HD, Discovery CT590 RT, Optima TM CT660, Optima CT540, Optima CT580, Optima CT580 W, Optima CT590 RT, LightSpeed TM Xtra, LightSpeed RT16, LightSpeed Pro32, LightSpeed VCT Select, LightSpeed VCT XT, LightSpeed VCT XTe, LightSpeed VCT, LightSpeed Pro16, LightSpeed 16 and BrightSpeed TM Elite. The following PET/CT and SPECT/CT systems that use the qualified CT systems are also eligible to receive the lung cancer screening option: Discovery IQ, Discovery PET/CT 610, Discovery PET/CT 710, Discovery CT670 with 16-slice CT and Discovery CT670 Pro.

Neurological Cancer
1. https://www.cancer.org/cancer/brain-spinal-cord-tumors-adults/about/key-statistics.html

Prostate Cancer:
1. Prostate Cancer Risk Factors [Internet]. WebMD. 2018 [cited 5 November 2018]. Available from: https://www.webmd.com/prostate-cancer/guide/prostate-cancer-risk-factors
2. Prostate cancer statistics [Internet]. World Cancer Research Fund. 2018 [cited 5 November 2018]. Available from: https://www.wcrf.org/dietandcancer/cancer-trends/prostate-cancer-statistics
3. Survival Rates for Prostate Cancer [Internet]. Cancer.org. 2018 [cited 5 November 2018]. Available from: https://www.cancer.org/cancer/prostate-cancer/detection-diagnosis-staging/survival-rates.html#written_by Patel AR, Klein EA.

Oncology Solutions

Oncology Solutions

ONCOLOGY SOLUTIONS

Oncology Pathways

The latest in Oncology

Precision Cancer Care

References: